6 results
The main objective of this study is to evaluate the ability of the PRECIZION Presbyopia IOL to provide near, intermediate and distance vision in patients undergoing cataract extraction and intraocular lens implantation. Study outcomes will be used…
Primary: To estimate the antitumor activity (assessed as overall response rate) of PDR001 as a single agent in patients with non-functional neuro-endocrine tumors (NET).Secondary: To estimate efficacy (duration of response) of PDR001. Safety and…
Primary Objective: To determine when straylight stabilizes in eyes after cataract surgery, determine the amount of straylight in eyes implanted with a Clareon monofocal IOL and a Vivinex XY1 monofocal IOL, and compare these straylight values to…
The primary objective of the study is to evaluate the efficacy and safety and rIFN-γ as adjunctive treatment in combination with standard therapy for the treatment of patients with candidemia. Efficacy is defined as clearance of candidemia within…
The main objective of this study is to evaluate the safety and effectiveness of the Artiflex Presbyopic IOL. It will be studied whether the IOL can provide satisfactory near, intermediate, and distance vision in subjects who desire spectacle…
* Safety Run inTo determine the recommended regimen of PDR001 in combination with dabrafenib and trametinib for the randomized part (part 3)* Biomarker cohortTo evaluate changes in the immune microenvironment and biomarker modulations upon treatment…